WINSUNBIO
839729
HIGO
872351
DRIVE
838275
4
Shanghai Menon Animal Nutrition Technology
301156
5
Nanjing Railway New Technology
301016
(Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow | ||||||||||
Goods sale service render cash | -7.95%2.39B | -14.71%1.43B | -41.09%651.46M | 27.02%3.22B | 69.02%2.59B | 51.30%1.68B | 97.31%1.11B | 21.12%2.53B | 33.39%1.53B | 30.48%1.11B |
Refunds of taxes and levies | -45.49%21.48M | -68.80%4.75M | 300.05%5.19M | 772.51%36.94M | -53.39%39.41M | -71.34%15.24M | -79.05%1.3M | -43.58%4.23M | 242.63%84.56M | 313.07%53.16M |
Cash received relating to other operating activities | -0.99%393.61M | -22.94%233.99M | 29.02%49.41M | 165.89%296.36M | 178.26%397.53M | 231.37%303.66M | 30.01%38.3M | -66.43%111.46M | -42.17%142.86M | -38.18%91.64M |
Adjustment items of operating cash inflws | ---0.01 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Cash inflows from operating activities | -7.52%2.8B | -16.37%1.67B | -38.36%706.06M | 34.06%3.55B | 72.00%3.03B | 59.25%2B | 92.15%1.15B | 8.96%2.65B | 23.89%1.76B | 24.01%1.25B |
Goods services cash paid | -18.74%2.13B | -17.64%1.53B | 7.53%680.91M | 24.21%3.11B | 66.60%2.62B | 57.32%1.86B | 3.95%633.23M | 20.10%2.51B | 34.62%1.57B | 42.55%1.18B |
Staff behalf paid | 31.77%347.64M | 55.06%239.11M | 30.14%132.23M | 22.22%407.91M | 3.55%263.82M | -0.21%154.21M | 59.15%101.61M | 46.41%333.74M | 45.32%254.77M | 52.05%154.54M |
All taxes paid | -5.29%188.67M | -17.99%105.26M | -46.79%54.77M | 3.57%242.33M | -16.49%199.22M | -4.71%128.35M | 25.67%102.94M | 252.40%233.98M | 212.58%238.57M | 204.77%134.69M |
Cash paid relating to other operating activities | 18.14%562.33M | -20.98%300.8M | -1.03%99.98M | 56.49%598.68M | 61.40%475.98M | 65.16%380.64M | 37.01%101.01M | 59.12%382.56M | 45.83%294.9M | 12.43%230.47M |
Cash outflows from operating activities | -9.30%3.22B | -13.72%2.18B | 3.10%967.89M | 26.20%4.36B | 50.74%3.56B | 48.26%2.53B | 13.29%938.79M | 31.85%3.46B | 45.56%2.36B | 44.21%1.7B |
Net cash flows from operating activities | 19.51%-423.82M | 3.69%-508.51M | -226.72%-261.82M | -0.42%-811.24M | 11.91%-526.55M | -17.56%-527.99M | 188.86%206.62M | -323.59%-807.88M | -200.32%-597.72M | -164.62%-449.14M |
Investing cash flow | ||||||||||
Cash received from disposal of investments | -93.43%2.7M | 179.80%2.02M | 11,990.35%726.82K | 538.88%281.55M | -12.07%41.15M | -98.60%721.44K | -99.67%6.01K | -88.54%44.07M | -85.72%46.8M | -55.87%51.66M |
Cash received from returns on investments | ---- | ---- | 2,688.94%6.7K | ---- | -99.29%12.38K | -98.90%9.34K | --240.17 | 7,601.99%4.19M | -96.37%1.75M | -96.86%848.52K |
Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | --3.75M | 86.93%3.75M | ---- | 1,233.27%10.95M | ---- | --2.01M | ---- | -1.32%821.06K | -52.47%135.39K | ---- |
Net cash received from disposal of subsidiaries and other business units | ---- | ---- | ---- | ---- | ---- | 1,879.74%7.02M | ---- | --203.63K | ---- | --354.51K |
Cash received relating to other investing activities | ---- | ---- | ---- | ---- | ---- | ---- | --700 | ---- | ---- | ---- |
Cash inflows from investing activities | -84.31%6.46M | -40.84%5.77M | 10,451.58%733.52K | 493.45%292.5M | -15.45%41.16M | -81.54%9.76M | -99.70%6.95K | -87.21%49.29M | -87.06%48.68M | -63.39%52.86M |
Cash paid to acquire fixed assets intangible assets and other long-term assets | -42.06%356.63M | -5.77%325.58M | -59.29%142.67M | 2.93%648.64M | 132.55%615.5M | 80.84%345.53M | 186.66%350.44M | -31.63%630.19M | -54.85%264.68M | -64.24%191.07M |
Cash paid to acquire investments | -47.47%16M | -47.07%16M | -19.17%15M | 49.01%77.13M | -56.04%30.46M | 2.47%30.23M | -37.09%18.56M | -71.20%51.76M | -59.70%69.28M | -75.43%29.5M |
Net cash paid to acquire subsidiaries and other business units | ---- | ---- | ---- | ---- | ---- | --18.71M | ---- | ---- | ---- | ---- |
Cash paid relating to other investing activities | ---- | ---- | ---- | --44.25M | -32.53%1.13M | ---- | --978.02K | ---- | --1.68M | ---- |
Cash outflows from investing activities | -42.41%372.63M | -13.41%341.58M | -57.38%157.67M | 12.92%770.02M | 92.80%647.09M | 78.84%394.47M | 143.81%369.98M | -38.09%681.95M | -55.73%335.64M | -66.29%220.57M |
Net cash flows from investing activities | 39.57%-366.17M | 12.71%-335.81M | 57.58%-156.93M | 24.52%-477.52M | -111.16%-605.93M | -129.39%-384.72M | -147.60%-369.97M | 11.64%-632.66M | 24.88%-286.95M | 67.12%-167.71M |
Financing cash flow | ||||||||||
Cash received from capital contributions | -74.41%4.14M | -74.44%4.14M | ---- | -85.30%39.3M | -83.74%16.17M | -67.38%16.18M | 29.20%5.17M | -59.40%267.4M | 383.94%99.42M | 141.49%49.61M |
-Including: Cash received from capital contributions by minority shareholders of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -93.90%24.5M | ---- | 345.45%24.5M |
Cash from borrowing | 14.66%3.55B | 4.20%2.59B | -4.27%1B | 72.74%4.35B | 129.78%3.09B | 110.97%2.49B | 75.61%1.05B | 11.30%2.52B | 42.60%1.35B | 46.64%1.18B |
Cash received relating to other financing activities | ---- | ---- | -62.41%4.14M | ---- | ---- | ---- | --11.02M | ---- | --100M | ---- |
Cash inflows from financing activities | 14.19%3.55B | 3.70%2.59B | -5.34%1.01B | 57.56%4.39B | 101.18%3.11B | 103.77%2.5B | 77.14%1.06B | -4.66%2.78B | 60.23%1.55B | 49.00%1.23B |
Borrowing repayment | 36.61%2.65B | 47.04%1.94B | 32.63%746.69M | 78.88%3.05B | 75.04%1.94B | 50.25%1.32B | 2.39%563M | -8.46%1.7B | 23.62%1.11B | 34.10%877.23M |
Dividend interest payment | 55.44%217.53M | -18.91%93.27M | 25.99%41.5M | 85.20%197.75M | 117.09%139.94M | 119.88%115.01M | 59.40%32.94M | -18.58%106.78M | -34.00%64.46M | 41.25%52.31M |
Cash payments relating to other financing activities | -58.37%24.17M | -66.53%4.55M | -38.08%210.69K | -2.99%58.41M | -12.88%58.05M | 182.02%13.59M | -55.90%340.28K | 159.01%60.21M | 4,321.55%66.63M | 219.80%4.82M |
Cash outflows from financing activities | 35.26%2.89B | 40.73%2.04B | 32.22%788.4M | 76.60%3.3B | 72.50%2.14B | 54.83%1.45B | 4.37%596.28M | -7.18%1.87B | 24.47%1.24B | 34.88%934.35M |
Net cash flows from financing activities | -32.21%658.4M | -47.10%557.95M | -53.44%216.78M | 18.65%1.09B | 217.43%971.18M | 259.71%1.05B | 1,553.49%465.59M | 0.96%914.73M | 1,076.16%305.95M | 123.56%293.2M |
Net cash flow | ||||||||||
Exchange rate change effecting cash and cash equivalents | -386.81%-1.28M | -977.52%-7.09M | -119.00%-804.31K | -29.68%-1.28M | -92.92%445.9K | 131.11%807.93K | 75.64%4.23M | 65.36%-985.36K | 2,273.64%6.29M | -83.93%-2.6M |
Net increase in cash and cash equivalents | 17.40%-132.87M | -305.51%-293.46M | -166.17%-202.78M | 61.14%-204.71M | 71.90%-160.85M | 143.77%142.79M | 187.22%306.47M | -14,755.30%-526.79M | 6.56%-572.43M | 40.68%-326.24M |
Add:Begin period cash and cash equivalents | -22.56%702.88M | -22.56%702.88M | -22.56%702.88M | -36.73%907.59M | -36.73%907.59M | -36.73%907.59M | -36.73%907.59M | -0.25%1.43B | -0.25%1.43B | -0.25%1.43B |
End period cash equivalent | -23.67%570.01M | -61.02%409.42M | -58.81%500.09M | -22.56%702.88M | -13.37%746.74M | -5.21%1.05B | 12.10%1.21B | -36.73%907.59M | 4.44%861.95M | 24.80%1.11B |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
Auditor | -- | -- | -- | Zhonghua Certified Public Accountants (Special General Partnership) | -- | -- | -- | Zhonghua Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.